Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	entity_11	entity_12	entity_13	entity_14	entity_15	entity_16	entity_17	entity_18	entity_19	entity_20	entity_21	entity_22	entity_23	json	split
Subsequent studies have revealed that ( i) cytoplasmic RelA is stably associated not only with I kappa B alpha but also with other ankyrin motif - rich proteins including the products of the NF - kappa B2 ( p100) and NF - kappa B1 ( p105) genes; ( ii) in contrast to RelA - I kappa B alpha, RelA - p100 cytoplasmic complexes are not dissociated following tumor necrosis factor alpha activation; ( iii) p100 functions as a potent inhibitor of RelA - mediated transcription in vivo; ( iv) the interaction of RelA and p100 involves the conserved Rel homology domain of both proteins but not the nuclear localization signal of RelA, which is required for I kappa B alpha binding; ( v) p100 inhibition of RelA function requires the C - terminal ankyrin motif domain, which mediates cytoplasmic retention of RelA; and ( vi) as observed with I kappa B alpha, nuclear RelA stimulates p100 mRNA and protein expression.	RelA,55,59,Protein	I kappa B alpha,95,110,Protein	NF - kappa B2,191,204,Protein	p100,207,211,Protein	NF - kappa B1,217,230,Protein	p105,233,237,Protein	RelA,267,271,Protein	I kappa B alpha,274,289,Protein	RelA,291,295,Protein	p100,298,302,Protein	tumor necrosis factor alpha,355,382,Protein	p100,402,406,Protein	RelA,442,446,Protein	RelA,506,510,Protein	p100,515,519,Protein	RelA,623,627,Protein	I kappa B alpha,651,666,Protein	p100,681,685,Protein	RelA,700,704,Protein	RelA,802,806,Protein	I kappa B alpha,835,850,Protein	RelA,860,864,Protein	p100,876,880,Protein	"[{""token"": ""RelA"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""NF - kappa B2"", ""start_span"": 191, ""end_span"": 204, ""type"": ""Protein""}, {""token"": ""p100"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 217, ""end_span"": 230, ""type"": ""Protein""}, {""token"": ""p105"", ""start_span"": 233, ""end_span"": 237, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 267, ""end_span"": 271, ""type"": ""Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 274, ""end_span"": 289, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 291, ""end_span"": 295, ""type"": ""Protein""}, {""token"": ""p100"", ""start_span"": 298, ""end_span"": 302, ""type"": ""Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 355, ""end_span"": 382, ""type"": ""Protein""}, {""token"": ""p100"", ""start_span"": 402, ""end_span"": 406, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 442, ""end_span"": 446, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 506, ""end_span"": 510, ""type"": ""Protein""}, {""token"": ""p100"", ""start_span"": 515, ""end_span"": 519, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 623, ""end_span"": 627, ""type"": ""Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 651, ""end_span"": 666, ""type"": ""Protein""}, {""token"": ""p100"", ""start_span"": 681, ""end_span"": 685, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 700, ""end_span"": 704, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 802, ""end_span"": 806, ""type"": ""Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 835, ""end_span"": 850, ""type"": ""Protein""}, {""token"": ""RelA"", ""start_span"": 860, ""end_span"": 864, ""type"": ""Protein""}, {""token"": ""p100"", ""start_span"": 876, ""end_span"": 880, ""type"": ""Protein""}]"	valid
